AR053141A1 - Imidazoles sustituidos con heterociclilamida - Google Patents
Imidazoles sustituidos con heterociclilamidaInfo
- Publication number
- AR053141A1 AR053141A1 ARP060100637A ARP060100637A AR053141A1 AR 053141 A1 AR053141 A1 AR 053141A1 AR P060100637 A ARP060100637 A AR P060100637A AR P060100637 A ARP060100637 A AR P060100637A AR 053141 A1 AR053141 A1 AR 053141A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- substituents
- group
- heteroaryl
- phenyl
- Prior art date
Links
- 125000001424 substituent group Chemical group 0.000 abstract 10
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 6
- 125000001072 heteroaryl group Chemical group 0.000 abstract 5
- 125000001028 difluoromethyl group Chemical group [H]C(F)(F)* 0.000 abstract 4
- 229910052736 halogen Inorganic materials 0.000 abstract 4
- 150000002367 halogens Chemical class 0.000 abstract 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 4
- 125000005034 trifluormethylthio group Chemical group FC(S*)(F)F 0.000 abstract 4
- -1 trifluoromethoxy, difluoromethoxy, monofluoromethoxy Chemical group 0.000 abstract 4
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 4
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 abstract 3
- 125000004454 (C1-C6) alkoxycarbonyl group Chemical group 0.000 abstract 3
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 3
- 125000004916 (C1-C6) alkylcarbonyl group Chemical group 0.000 abstract 3
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 abstract 3
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 3
- ORTFAQDWJHRMNX-UHFFFAOYSA-N hydroxidooxidocarbon(.) Chemical group O[C]=O ORTFAQDWJHRMNX-UHFFFAOYSA-N 0.000 abstract 3
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 3
- 125000004043 oxo group Chemical group O=* 0.000 abstract 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 3
- 150000003839 salts Chemical class 0.000 abstract 2
- 239000012453 solvate Substances 0.000 abstract 2
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 abstract 1
- 125000006570 (C5-C6) heteroaryl group Chemical group 0.000 abstract 1
- 125000000041 C6-C10 aryl group Chemical group 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 239000003443 antiviral agent Substances 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Composiciones farmacéuticas que los contienen, usos como agentes antivirales y método de preparacion. Reivindicacion 1: Compuesto de formula (1) en la que R1 representa un grupo de formula (2) o (3) en la que * representa el lugar de union al grupo carbonilo; R4 representa fenilo o heteroarilo de 5 o 6 miembros, en el que fenilo y heteroarilo pueden estar sustituidos con 1 a 3 sustituyentes, en los que los sustituyentes se seleccionan independientemente unos de otros del grupo constituido por halogeno, hidroxi, oxo, nitro, ciano, trifluorometilo, difluorometil, trifluorometoxi, difluorometoxi, monofluorometoxi, trifluorometiltio, alquilo C1-6, alcoxi C1-6, hidroxicarbonilo, alcoxi C1-6-carbonilo, amino, alquil C1-6-amino, aminocarbonilo y alquil C1-6-aminocarbonilo; R5 representa fenilo o heteroarilo de 5 o 6 miembros en el que fenilo y heteroarilo pueden estar sustituidos con 1 a 3 sustituyentes, en los que los sustituyentes se seleccionan independientemente unos de otros del grupo constituido por halogeno, hidroxi, oxo, nitro, ciano, trifluorometilo, difluorometilo, trifluorometoxi, difluorometoxi, monofluorometoxi, trifluorometiltio, alquilo C1-6, alcoxi C1-6, hidroxicarbonilo, alcoxi C1-6-carbonilo, amino, alquil C1-6- amino, aminocarbonilo y alquil C1-6-aminocarbonilo y R6 y R7 representan independientemente uno del otro H, metilo o etilo; R2 representa alquilo C1-6, en el que alquilo puede estar sustituido con un sustituyente, en el que el sustituyente se selecciona del grupo constituido por cicloalquilo C3-6, aril C6-10 y heteroarilo de 5 a 6 miembros, pudiendo estar cicloalquilo, arilo y heteroarilo sustituidos con 1 a 3 sustituyentes, en los que los sustituyentes se seleccionan independientemente unos de otros del grupo constituido por halogeno, hidroxi, oxo, nitro, ciano, trifluorometilo, difluorometilo, trifluorometoxi, difluorometoxi, monofluorometoxi, trifluorometiltio, alquilo C1-6, alcoxi C1-6, hidroxicarbonilo, alcoxi C1-6-carbonilo, amino, alquil C1-6-amino, aminocarbonilo y alquil C1-6-aminocarbonilo; R3 representa fenilo, en el que fenilo puede estar sustituido con 1 a 3 sustituyentes, en el que los sustituyentes se seleccionan independientemente unos de otros del grupo constituido por halogeno, hidroxi, trifluorometilo, difluorometilo, trifluorometoxi, difluorometoxi, monofluorometoxi, trifluorometiltio, alquilo C1-6 y alcoxi C1-6, o una de sus sales, sus solvatos o los solvatos de sus sales.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102005008183A DE102005008183A1 (de) | 2005-02-23 | 2005-02-23 | Heterocyclylamid-substituierte Imidazole |
Publications (1)
Publication Number | Publication Date |
---|---|
AR053141A1 true AR053141A1 (es) | 2007-04-25 |
Family
ID=36675125
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP060100637A AR053141A1 (es) | 2005-02-23 | 2006-02-22 | Imidazoles sustituidos con heterociclilamida |
Country Status (29)
Country | Link |
---|---|
US (1) | US7919489B2 (es) |
EP (1) | EP1853582B1 (es) |
JP (1) | JP5208522B2 (es) |
KR (1) | KR101276003B1 (es) |
CN (1) | CN101128455B (es) |
AR (1) | AR053141A1 (es) |
AT (1) | ATE446292T1 (es) |
AU (1) | AU2006218276C1 (es) |
BR (1) | BRPI0607995B8 (es) |
CA (1) | CA2598521C (es) |
DE (2) | DE102005008183A1 (es) |
DK (1) | DK1853582T3 (es) |
ES (1) | ES2333249T3 (es) |
GT (1) | GT200600077A (es) |
HK (1) | HK1110857A1 (es) |
HN (2) | HN2006007774A (es) |
IL (1) | IL185050A (es) |
MX (1) | MX2007010308A (es) |
MY (1) | MY140543A (es) |
NO (1) | NO338997B1 (es) |
NZ (1) | NZ560811A (es) |
PE (2) | PE20100233A1 (es) |
PL (1) | PL1853582T3 (es) |
PT (1) | PT1853582E (es) |
RU (1) | RU2415851C2 (es) |
TW (1) | TWI388553B (es) |
UY (1) | UY29387A1 (es) |
WO (1) | WO2006089664A2 (es) |
ZA (1) | ZA200707412B (es) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102004015007A1 (de) | 2004-03-26 | 2005-10-13 | Bayer Healthcare Ag | Substituierte Imidazole |
DE102005008183A1 (de) | 2005-02-23 | 2006-08-31 | Bayer Healthcare Ag | Heterocyclylamid-substituierte Imidazole |
DE102011101446A1 (de) * | 2011-05-10 | 2012-11-15 | Aicuris Gmbh & Co. Kg | Herstellung von "Dense Bodies" (DB) |
DE102011113749A1 (de) * | 2011-09-14 | 2013-03-14 | Aicuris Gmbh & Co. Kg | Sulfonsäuresalze Heterocyclylamid-substituiertr Imidazole |
CN104610160A (zh) * | 2013-11-04 | 2015-05-13 | 南京大学 | 含哌嗪环的5-硝基咪唑类衍生物及其制备与在抗菌药物中的应用 |
CN104016925B (zh) * | 2014-06-17 | 2016-03-30 | 遵义医学院 | 4-烷基咪唑-2-羧酸的合成方法 |
KR20180028456A (ko) * | 2015-06-22 | 2018-03-16 | 다이닛본 스미토모 세이야꾸 가부시끼가이샤 | 1,4-디치환 이미다졸 유도체 |
JP6507976B2 (ja) * | 2015-09-30 | 2019-05-08 | 東レ株式会社 | イミダゾール−2−カルボン酸エステル誘導体又はその塩の製造方法 |
CN116120238B (zh) * | 2023-03-01 | 2023-09-22 | 山东梅奥华卫科技有限公司 | 一种咪唑衍生物的制备方法 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6342501B1 (en) | 1994-02-25 | 2002-01-29 | The Regents Of The University Of Michigan | Pyrrolo[2,3-d] pyrimidines as antiviral agents |
JP4344960B2 (ja) * | 1997-05-23 | 2009-10-14 | バイエル、コーポレイション | アリール尿素によるp38キナーゼ活性の阻害 |
US6080763A (en) | 1997-11-03 | 2000-06-27 | Boehringer Ingelheim Pharmaceuticals, Inc. | Aromatic heterocyclic compounds and their use as anti-inflammatory agents |
AU2353900A (en) | 1998-12-09 | 2000-06-26 | Wyeth | Heterocyclic carboxamide-containing thiourea inhibitors of herpes viruses containing a substituted phenylenediamine group |
DE10257358A1 (de) | 2002-12-09 | 2004-07-08 | Bayer Healthcare Ag | Substituierte Pyrrole |
DE102004015007A1 (de) * | 2004-03-26 | 2005-10-13 | Bayer Healthcare Ag | Substituierte Imidazole |
AU2005245399A1 (en) * | 2004-05-12 | 2005-12-01 | Schering Corporation | CXCR1 and CXCR2 chemokine antagonists |
DE102005008183A1 (de) | 2005-02-23 | 2006-08-31 | Bayer Healthcare Ag | Heterocyclylamid-substituierte Imidazole |
-
2005
- 2005-02-23 DE DE102005008183A patent/DE102005008183A1/de not_active Ceased
-
2006
- 2006-02-14 PL PL06706932T patent/PL1853582T3/pl unknown
- 2006-02-14 AT AT06706932T patent/ATE446292T1/de active
- 2006-02-14 DE DE502006005182T patent/DE502006005182D1/de active Active
- 2006-02-14 EP EP06706932A patent/EP1853582B1/de active Active
- 2006-02-14 DK DK06706932.8T patent/DK1853582T3/da active
- 2006-02-14 CN CN2006800056123A patent/CN101128455B/zh not_active Expired - Fee Related
- 2006-02-14 ZA ZA200707412A patent/ZA200707412B/xx unknown
- 2006-02-14 NZ NZ560811A patent/NZ560811A/en unknown
- 2006-02-14 RU RU2007135277/04A patent/RU2415851C2/ru active
- 2006-02-14 BR BRPI0607995A patent/BRPI0607995B8/pt not_active IP Right Cessation
- 2006-02-14 WO PCT/EP2006/001325 patent/WO2006089664A2/de active Application Filing
- 2006-02-14 AU AU2006218276A patent/AU2006218276C1/en not_active Ceased
- 2006-02-14 JP JP2007556526A patent/JP5208522B2/ja not_active Expired - Fee Related
- 2006-02-14 KR KR1020077021862A patent/KR101276003B1/ko active IP Right Grant
- 2006-02-14 MX MX2007010308A patent/MX2007010308A/es active IP Right Grant
- 2006-02-14 CA CA2598521A patent/CA2598521C/en not_active Expired - Fee Related
- 2006-02-14 ES ES06706932T patent/ES2333249T3/es active Active
- 2006-02-14 PT PT06706932T patent/PT1853582E/pt unknown
- 2006-02-16 GT GT200600077A patent/GT200600077A/es unknown
- 2006-02-20 UY UY29387A patent/UY29387A1/es not_active Application Discontinuation
- 2006-02-21 HN HN2006007774A patent/HN2006007774A/es unknown
- 2006-02-21 MY MYPI20060736A patent/MY140543A/en unknown
- 2006-02-22 TW TW095105843A patent/TWI388553B/zh not_active IP Right Cessation
- 2006-02-22 PE PE2010000032A patent/PE20100233A1/es active IP Right Grant
- 2006-02-22 PE PE2006000214A patent/PE20061141A1/es active IP Right Grant
- 2006-02-22 AR ARP060100637A patent/AR053141A1/es active IP Right Grant
-
2007
- 2007-08-06 IL IL185050A patent/IL185050A/en active IP Right Grant
- 2007-08-20 US US11/894,307 patent/US7919489B2/en not_active Expired - Fee Related
- 2007-09-19 NO NO20074780A patent/NO338997B1/no not_active IP Right Cessation
-
2008
- 2008-05-09 HK HK08105221.2A patent/HK1110857A1/xx not_active IP Right Cessation
-
2010
- 2010-01-18 HN HN2010000128A patent/HN2010000128A/es unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR053141A1 (es) | Imidazoles sustituidos con heterociclilamida | |
AR086474A1 (es) | Compuestos de pirazol pesticidas | |
AR114064A2 (es) | Compuestos insecticidas basados en derivados de isoxazolina | |
CY1119101T1 (el) | Ναφθαλινο-ισοξαζολινες ως παραγοντες καταπολεμισης ασπονδυλων παρασιτων | |
AR108745A1 (es) | Derivados de oxadiazol microbiocidas | |
AR069417A1 (es) | Piperidinas heteroaril - sustituidas | |
AR083081A1 (es) | Isoxazolin oximas como agentes antiparasitarios | |
AR073369A1 (es) | Derivados de 2-carboxamida-cicloamino-urea como inhibidores de pi-3 | |
AR061369A1 (es) | Derivados de pirimidina y composiciones farmaceuticas que los comprenden | |
AR074109A1 (es) | Pirrolidinas heterociclicas agonistas de receptores de la melanocortina, composiciones farmaceuticas que las contienen y uso de las mismas en el tratamiento de la obesidad, diabetes y disfuncion erectil. | |
AR073136A1 (es) | Compuestos de pirrol | |
ES2590504T3 (es) | N-ciclilamidas como nematicidas | |
AR055360A1 (es) | Inhibidores macrociclicos del virus de la hepatitis c | |
AR053774A1 (es) | Derivados de sulfonilbencimidazol. composiciones farmaceuticas. | |
CO6260076A2 (es) | Derivados de uracilo o timina para el tratamiento de la hepatitis c | |
AR088625A1 (es) | Derivados de aril-quinolina | |
AR077818A1 (es) | Composiciones pesticidas | |
AR039665A1 (es) | Fenilacetamidas sustituidas y su uso como activadores de glucoquinasa | |
AR057109A1 (es) | Benzimidazoles sustituidos y metodos para usarlos como inhibidores de las quinasas asociadas con la tumorigenesis | |
AR059184A1 (es) | Derivados de sulfonamidas, su preparacion y su aplicacion en tarapeutica | |
ES2601518T3 (es) | Composiciones plaguicidas | |
ES2377337T3 (es) | Derivados pirimidina y su uso como antogonistas del receptor P2Y12 | |
AR067327A1 (es) | Derivados de piperidina / piperazina | |
AR061370A1 (es) | Derivados de imidazopirimidina | |
UY30897A1 (es) | Derivados de pentafluorotiobenzamidoacetonitrilo, composiciones conteniéndolos y aplicaciones |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant, registration |